Viewing Study NCT02085603


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-03-10 @ 8:37 PM
Study NCT ID: NCT02085603
Status: COMPLETED
Last Update Posted: 2018-04-13
First Post: 2014-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STH16404
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View